CRISPR Therapeutics and Vertex presents new data on more patients with longer follow-up treated with exagamglogene autotemcel (exa-cel) Clinical Impact Jun 11 Written By Frances Benson http://www.crisprtx.com/about-us/press-releases-and-presentations/vertex-and-crispr-therapeutics-present-new-data-on-more-patients-with-longer-follow-up-treated-with-exagamglogene-autotemcel-exa-cel-at-the-2022-european-hematology-association-eha-congress 2022 Frances Benson
CRISPR Therapeutics and Vertex presents new data on more patients with longer follow-up treated with exagamglogene autotemcel (exa-cel) Clinical Impact Jun 11 Written By Frances Benson http://www.crisprtx.com/about-us/press-releases-and-presentations/vertex-and-crispr-therapeutics-present-new-data-on-more-patients-with-longer-follow-up-treated-with-exagamglogene-autotemcel-exa-cel-at-the-2022-european-hematology-association-eha-congress 2022 Frances Benson
